Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria.
Kidney Int Rep. 2022 May 26;7(8):1831-1841. doi: 10.1016/j.ekir.2022.05.017. eCollection 2022 Aug.
Kidney Int Rep. 2022.
PMID: 35967104
Free PMC article.
Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus.
Wallace DJ, Isenberg DA, Morand EF, Vazquez-Mateo C, Kao AH, Aydemir A, Pudota K, Ona V, Aranow C, Merrill JT.
Wallace DJ, et al. Among authors: pudota k.
Rheumatology (Oxford). 2021 Nov 3;60(11):5379-5389. doi: 10.1093/rheumatology/keab115.
Rheumatology (Oxford). 2021.
PMID: 33547784
Clinical Trial.
Item in Clipboard
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.
Morand EF, Isenberg DA, Wallace DJ, Kao AH, Vazquez-Mateo C, Chang P, Pudota K, Aranow C, Merrill JT.
Morand EF, et al. Among authors: pudota k.
Rheumatology (Oxford). 2020 Oct 1;59(10):2930-2938. doi: 10.1093/rheumatology/keaa029.
Rheumatology (Oxford). 2020.
PMID: 32107560
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite